ICG-001 is a research compound that functions as a selective inhibitor of the CREB-binding protein (CBP) and p300 interaction with β-catenin. It is primarily used in laboratory studies to investigate the role of CBP/p300 in cellular signaling and gene transcription.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 847591-62-2
5-Methoxyuridine 5'-triphosphate
nucleotide triphosphate research reagent
(S)-2-(Methylamino)-3-phenylpropan-1-ol
research compound
Compound 48/80 (trihydrochloride)
research compound
5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-carbaldehyde
synthetic intermediate for boron-containing compounds
(6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-8-(naphthalen-1-ylmethyl)-4,7-dioxo-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide
HQWTUOLCGKIECB-XZWHSSHBSA-N
C1CN([C@H]2CN(C(=O)[C@@H](N2C1=O)CC3=CC=C(C=C3)O)CC4=CC=CC5=CC=CC=C54)C(=O)NCC6=CC=CC=C6